ITP affects about 5 people per 10,000. It can be associated with other conditions that are hematologic (leukemia) or ...
Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...
MedPage Today on MSN
Novel ITP drug helps patients ditch daily meds
ORLANDO -- Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily ...
A late-breaking presentation at the American Society of Hematology (ASH) 2025 meeting revealed promising phase 3 findings for ...
Immune thrombocytopenia, previously known as idiopathic thrombocytopenic purpura (ITP), causes you to have a low platelet count. This may result in excessive bleeding inside and outside your body.
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or ...
Islamabad Traffic Police (ITP) on Thursday announced that the entry of all kinds of heavy traffic into the federal capital will ...
Islamabad Traffic Police (ITP) have deployed more than 200 traffic officers across the federal capital to ensure smooth ...
ITP Aero is to further reinforce its growing MRO business with the acquisition of Stavanger-based Aero Norway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results